RPTX News
Archived Headlines
- Preclinical biotech Repare Therapeutics ups share offering, range ahead of $190 million IPO 06/17/20
- Preclinical oncology biotech Repare Therapeutics sets terms for $125 million IPO 06/15/20
- US IPO Week Ahead: Royalty Pharma leads a 5 IPO week 06/12/20
- US IPO Weekly Recap: 5 IPOs launch during the 4-day week 05/29/20
- Preclinical oncology biotech Repare Therapeutics files for a $100 million IPO 05/29/20
US IPO Week Ahead: The IPO market makes a holiday WISH in a 6 IPO week
Updated Monday, 12/14. Six IPOs and five SPACs are scheduled to raise $2.8 billion in the week ahead as the IPO market starts to slow down before the holidays. Bargain e-commerce platform Wish (WISH) plans to raise $1.1...read more
US IPO Week Ahead: GoHealth takes the lead in a 9 IPO Week
Updated Monday, 7/13. Nine IPOs and one SPAC plan to raise $1.5 billion in the week ahead, led by health insurance marketplace GoHealth (GOCO). More deals could join the IPO calendar in the week ahead, including Apple workflow...read more
US IPO Weekly Recap: Royalty Pharma takes the crown in 5 IPO week
Five IPOs and one SPAC went public this past week led by Royalty Pharma (RPRX), which completed the largest US IPO of 2020 to date. Healthcare continued to dominate, with all five IPOs coming from the sector. Royalty Pharma (RPRX)...read more
Repare Therapeutics prices further upsized IPO at $20, the high end of the upwardly revised range
Repare Therapeutics, a preclinical biotech developing gene therapies for solid tumors, raised $220 million by offering 11 million shares at $20, the high end of the upwardly revised range of $18 to $20. On Wednesday, the company raised the proposed IPO range and...read more